Results 101 to 110 of about 44,151 (306)
United European Gastroenterology Journal, EarlyView.ABSTRACT Background It remains unclear whether the addition of non‐selective beta‐blockers (NSBB) provides further benefit after combined use of tissue adhesive and endoscopic variceal ligation for bleeding gastroesophageal varices. Objective This is the first cohort study comparing the secondary prophylactic efficacy of adding NSBB to combined ...
Ling Wu +7 more
wiley +1 more source
Effect of carvedilol on atrial excitation-contraction coupling, Ca release and arrhythmogenicity.
American Journal of Physiology. Heart and Circulatory Physiology, 2020 Carvedilol is an FDA-approved β-blocker commonly used for treatment of high blood pressure, congestive heart failure and cardiac tachyarrhythmias, including atrial fibrillation.
Elizabeth Martinez-Hernandez, L. Blatter
semanticscholar +1 more source
United European Gastroenterology Journal, EarlyView.ABSTRACT Background and Aims Hepatic encephalopathy is a frequent complication of cirrhosis. Rifaximin‐α has been included in guidelines for secondary prevention of hepatic encephalopathy, but there are few real‐world data on its efficacy and impact on healthcare utilization.
Diederick J. van Doorn +10 more
wiley +1 more source
International Journal of Molecular Sciences, 2020 The β-blocker carvedilol prevents ultraviolet (UV)-induced skin cancer, but the mechanism is unknown. Since carvedilol possesses antioxidant activity, this study investigated whether carvedilol prevents oxidative photodamage of skin, a precursor event in
Mengbing Chen +4 more
semanticscholar +1 more source
Endocrinology, Diabetes & Metabolism, 2021 Aim It has been suggested that repeated activation of the adrenergic system during antecedent episodes of hypoglycaemia contributes to the development of counterregulatory failure.
Rawad Farhat +5 more
doaj +1 more source
FORMULATION AND CHARACTERIZATION OF CARVEDILOL NANOEMULSION ORAL LIQUID DOSAGE FORM [PDF]
, 2015 Objective: Carvedilol is antihypertensive. It is practically water insoluble. Therefore, the objective of this investigation is a formulation and characterization of carvedilol nano emulsion (NE) employing orally to increase carvedilol solubility for ...
Drais, Hayder Kadhim +1 more
core
Partial pharmacologic blockade shows sympathetic connection between blood pressure and cerebral blood flow velocity fluctuations [PDF]
, 2016 Cerebral autoregulation (CA) dampens transfer of blood pressure (BP)-fluctuations onto cerebral blood flow velocity (CBFV). Thus, CBFV-oscillations precede BP-oscillations.
Hauck, P +10 more
core +1 more source
Cardioprotective Potential of Carvedilol
Cardiology, 1993 Carvedilol is a multiple-action cardiovascular agent that is a nonselective beta-adrenoceptor antagonist and a vasodilator. beta-Adrenoceptor antagonists reduce myocardial work, secondary to reductions in heart rate and contractility, both in animals and in humans. For these reasons, carvedilol may improve survival of acutely ischemic myocardium.
Antoine Bril +2 more
openaire +3 more sources
Российский кардиологический журнал, 2001 We have examinated 106 patients with primary acute myocardial Q-infarction. Favourable effects of carvedilol on basic parameters of central, intracardial and peripheral hemodynamic was identificated.
L. N. Mingazetdinova +5 more
doaj
Effect of Carvedilol vs Metoprolol Succinate on Mortality in Heart Failure with Reduced Ejection Fraction [PDF]
, 2018 Background Beta blocker therapy is indicated in all patients with heart failure with reduced ejection fraction (HFrEF) as per current guidelines. The relative benefit of carvedilol to metoprolol succinate remains unknown.
Kahee Mohammed +5 more
core +1 more source